Sanofi-Aventis may initiate hostile takeover of Genzyme

French pharmaceutical company Sanofi-Aventis SA may initiate a hostile takeover of US biotech company Genzyme Corp. if the management of the latter refuses the acquisition offer, Citgroup Inc. analysts believe. Mark Dainty and Yaron Werber.

Leave a Comment

Your email address will not be published. Required fields are marked *